Fluidigm Corporation (FLDM) Insider Buys $116,369.80 in Stock

Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 20,380 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were acquired at an average cost of $5.71 per share, with a total value of $116,369.80. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Friday, November 17th, Levin Capital Strategies, L.P. purchased 6,880 shares of Fluidigm stock. The shares were acquired at an average cost of $5.05 per share, with a total value of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. purchased 54,900 shares of Fluidigm stock. The shares were acquired at an average cost of $5.26 per share, with a total value of $288,774.00.
  • On Wednesday, October 25th, Levin Capital Strategies, L.P. purchased 4,227 shares of Fluidigm stock. The shares were acquired at an average cost of $5.42 per share, with a total value of $22,910.34.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. bought 22,363 shares of Fluidigm stock. The shares were purchased at an average cost of $5.47 per share, with a total value of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. bought 60,000 shares of Fluidigm stock. The shares were purchased at an average cost of $4.55 per share, with a total value of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. bought 144,200 shares of Fluidigm stock. The shares were purchased at an average cost of $4.59 per share, with a total value of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. bought 50,000 shares of Fluidigm stock. The shares were purchased at an average cost of $4.59 per share, with a total value of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. bought 95,843 shares of Fluidigm stock. The shares were purchased at an average cost of $4.57 per share, with a total value of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm stock. The stock was bought at an average price of $5.25 per share, for a total transaction of $315,000.00.

Shares of Fluidigm Corporation (NASDAQ:FLDM) traded up $0.36 during midday trading on Thursday, hitting $5.95. The company had a trading volume of 327,899 shares, compared to its average volume of 257,912. The company has a current ratio of 3.02, a quick ratio of 2.46 and a debt-to-equity ratio of 5.00. Fluidigm Corporation has a 52 week low of $2.52 and a 52 week high of $8.69.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. American International Group Inc. grew its position in Fluidigm by 7.1% in the first quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock valued at $102,000 after acquiring an additional 1,187 shares during the last quarter. Virtu KCG Holdings LLC bought a new position in Fluidigm in the second quarter valued at about $105,000. Sei Investments Co. grew its position in Fluidigm by 221.7% in the third quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 14,932 shares during the last quarter. PDT Partners LLC grew its position in Fluidigm by 56.0% in the second quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after acquiring an additional 9,800 shares during the last quarter. Finally, Group One Trading L.P. grew its position in Fluidigm by 336.9% in the third quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after acquiring an additional 17,855 shares during the last quarter. Institutional investors own 93.33% of the company’s stock.

Separately, ValuEngine cut Fluidigm from a “sell” rating to a “strong sell” rating in a research report on Thursday, November 9th.

COPYRIGHT VIOLATION WARNING: This news story was reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/30/fluidigm-corporation-fldm-insider-buys-116369-80-in-stock.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply